Skip Main Navigation

Programme Overview

Friday, November 12, 2010

07:30-08:30 Workshop on Clinical Trial Design - John A "Drew" Ridge
08:50-09:00 Welcome - Jim Bonner
9:00-09:50 Opening keynote lecture (moderator: Jim Bonner)
  HPV-associated cancers on the rise, a growing problem? - Margaret Stanley
09:50-10:20 Coffee break
10:20-12:00 Joint session (moderator: Margaret Stanley)
HPV vaccines: current issues in HPV-associated cancers
10:20 Screening women vaccinated for HPV16/18 - Jack Cuzick
10:45 Vaccination for boys: the paediatrician's perspective - Hal Jenson
11:10 Community randomised Phase IV HPV vaccination effectiveness trial: Baseline characteristics and trial deliverables - Matti Lehtinen
11:35 Vaccine development in the developing world - John Sellors
12:00 Session ends
12:00-13:30 Lunch break
13:30-15:10 Parallel session (moderator: Chris Meijer)
  Risk assessment and treatment in cervical cancer
13:30 Management of screen-detected HPV-positive women- Guglielmo Ronco
13:55 Risk of high-grade CIN in women with HPV infection: role of persistence and genotyping - Nicolas Wentzensen
14:20 Organisation of HPV-based screening - Ahti Anttila
14:45 Age issues in HPV screening - Guglielmo Ronco
15:10 Session ends
13:30-15:10 Parallel session (moderator: Maura Gillison)
  New agents in head and neck cancer
13:30 HPV and incidence trends for head and neck cancer - Anil Chaturvedi
13:55 The new era of targeted agents in head and neck cancer - Jim Bonner
14:20 Side effects of the new targeted agents in head and neck cancer - Jean Pierre Armand
14:45 Critical assessment of the role of chemotherapy, surgery, and radiation therapy in HPV-related oropharyngeal cancer and future clinical trials - Marshall Posner
15:10 Session ends
15:10-15:40 Tea break
15:40-17:20 Joint session (moderator: Marshall Posner)
  Clinical trial design in relation to HPV-associated disease
15:40 HPV and clinical trial design for head and neck cancer - Maura Gillison
16:05 The importance of window of opportunity studies - Jan Vermorken
16:30 Long-term efficacy of HPV vaccination against hard end-points: Cancer registry based follow-up of phase III efficacy trials - Jorma Paavonen
16:55 Ecological competition of vaccine-type and non-vaccine-type HPVs before and after mass vaccination - Matti Lehtinen
17:20 Session ends
17:20 End of day

Saturday, November 13, 2010

9:00-10:40 Parallel session (moderator: Jorma Paavonen)
  HPV testing, translational research, and the clinic
09:00 HPV testing in the developing world - John Sellors
09:25 Use of biomarkers in HPV screening programmes - Nicolas Wentzensen
09:50 Is HPV prognostic, predictive, or both? - Lisa Licitra
10:15 Therapeutic HPV vaccines - Cornelia Trimble
10:40 Session ends
9:00-10:40 Parallel session (moderator: Jens Overgaard)
  Management of mouth and oral-pharyngeal cancers in relation to HPV
09:00 Prevalence, natural history, and transmission of oral HPV in relation to oropharyngeal cancer- Gypsyamber Dsouza
09:25 HPV-specific genetic markers in HPV-associated head and neck and cervical cancers- Peter Snijders
09:50 Neck dissection in the surgical management of oropharyngeal cancer: controversies and outstanding questions - Ian Martin
10:15 Evolving treatment paradigms in the management of oropharyngeal cancer - Maura Gillison
10:40 Session ends
10:40-11:10 Coffee break
11:10-12:25 Joint session (moderator: Joel Palefsky)
  Genetics, environment, and lifestyle factors
11:10 HPV infection in pregnancy: issues in relation to prophylactic and therapeutic strategies - Jorma Paavonen
11:35 Co-morbidity and smoking behaviour in HPV positive and negative HNSCC patients in relation to outcome - Jens Overgaard
12:00 Race and ethnicity in HPV-related oropharyngeal cancer - Kevin Cullen
12:25 Session ends
12:25-14:00 Lunch break
14:00-15:15 Parallel session (moderator: Guglielmo Ronco)
  Penile and anal cancers: biology and current management
14:00 Prevention and treatment approaches to AIN and anal cancer - Joel Palefsky
14:25 Prophylactic vaccines for anogenital cancer - Margaret Stanley
14:50 Circumcision for prevention of ano-genital and oral cancers? - Tim Oliver
15:15 Session ends
14:00-15:15 Parallel session (moderator: Jean Pierre Armand)
  Radiation in HPV-infected head and neck and oral-pharyngeal cancers
14:00 Radiation in HPV-infected head and neck and oral pharyngeal cancers - Pernille Lassen
14:25 Rationale for radiation dose reduction in HPV-related oropharyngeal cancer - Marshall Posner
14:50 Hypoxia, HPV, and radiotherapy: interactions and implications for outcome - Jens Overgaard
15:15 Session ends
15:20-16:10 Closing keynote lecture (moderator: Jim Bonner)
  HPV infection in the HIV-positive host: molecular interactions and clinical implications - Joel Palefsky
16:10-16:20 Closing remarks - Jim Bonner

Programme is correct at time of publication

Advertisement